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Purpose: Stargardt disease (STGD), characterized by central visual impairment, is the most common juvenile macular
dystrophy. All recessively inherited cases are thought to be due to mutations in the ABCA4 gene. Early-onset autosomal
recessive retinitis pigmentosa (arRP) is a severe retinal degeneration that presents before the patient is ten years old. It
has been associated with mutations in different genes, including CRB1. The aim of this study was to determine the genetic
causes for two different retinal dystrophies, STGD and early-onset arRP, both segregating in one Spanish family.
Methods: Mutational analyses were performed using the ABCR400 and Leber congenital amaurosis (LCA) genotyping
microarrays. Additional scanning for mutations was conducted by denaturing high performance liquid chromatography
(dHPLC); results were confirmed by direct sequencing.
Results: A patient, who exhibited a STGD phenotype, was found to be homozygous for the p.Asn1805Asp (c.5413A>G)
mutation in ABCA4. However, his affected sister, who had the arRP phenotype, was found to be heterozygous for this
allele; no other sequence change could be found in ABCA4. Analysis using the LCA chip revealed the p.Cys948Tyr
mutation in CRB1 in heterozygous state. A second mutation (p.Trp822ter) was found in the CRB1 gene in the affected
female by denaturing high performance liquid chromatography (dHPLC) and direct sequencing.
Conclusions: Two distinct retinal dystrophies with mutations affecting two different genes cosegregated in this family.
The presence of two different phenotypes associated with mutations in two distinct genes in one single family must be
considered especially when dealing with retinal dystrophies which bear high carrier frequencies in general population.
Stargardt disease (STGD1, MIM #248200) is the most
common  hereditary  macular  dystrophy  affecting  children,
with  a  prevalence  of  approximately  1:10000  [1].  It  is
characterized by central visual loss, atrophy of the retinal
pigment epithelium (RPE) that resembles a “beaten-bronze
appearance,”  and  the  distribution  of  orange  yellow  flecks
around  the  macula  and/or  midperiphery  of  the  retina  [2].
STGD is predominantly inherited as an autosomal recessive
trait, although an autosomal dominant form has been also
described [3]. Biallelic mutations in ABCA4 are found in most
patients with autosomal recessive STGD (arSTGD) [4] as well
as  in  some  patients  with  autosomal  recessive  retinitis
pigmentosa  (arRP)  [5]  and  autosomal  recessive  cone-rod
dystrophy  (arCRD)  [6].  Heterozygote  carrier  frequency  is
particularly high in the general population [7].
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RP  with  paraarteriolar  preservation  of  RPE  (RP12,
MIM#600105)  is  a  specific  form  of  RP  characterized  by
preserved paraarteriolar RPE (PPRPE) in the early-to-middle
stages of disease. Patients experience night blindness and
develop a progressive loss of visual fields before they are 10
years old. By the time they are 20, patients have severe visual
impairment  because  of  early  macular  involvement.  Other
features  reported  with  this  type  of  RP  are  hyperopia,
nystagmus, optic-nerve–head drusen, vascular sheathing, and
maculopathy [8,9]. Mutations in the CRB1 (Crumbs homolog
1) gene have been found in patients with RP12, with and
without  PPRPE,  RP  patients  who  developed  Coats-like
exudative vasculopathy, and in 10%–13% of patients with
Leber  congenital  amarousis  (LCA).  This  gene  maps  to
chromosome 1q31.3 and contains 12 exons. RP caused by
CRB1 mutations is inherited in an autosomal recessive manner
[10-12].
In  this  study,  we  used  the  ABCR400  and  LCA
microarrays to investigate the disease-causing mutations in
Molecular Vision 2008; 14:262-267 <http://www.molvis.org/molvis/v14/a32>
Received 8 August 2007 | Accepted 10 January 2008 | Published 4 February 2008
© 2008 Molecular Vision
262one  family  who  presented  with  two  distinct  phenotypes:
STDG and early onset RP with a PPRPE phenotype.
METHODS
Ascertainment of patients: This molecular study was reviewed
and approved by the Ethics Committee of Fundacion Jimenez
Diaz, and it was performed according to the tenets of the
Declaration of Helsinki and further reviews (Edinburgh, 2000;
www.wma.net).  A  total  number  of  129  Spanish  families
affected with different retinal dystrophies due to mutations in
the ABCA4 gene were studied. Of these, we selected one
family  segregating  both  STGD  and  early-onset  arRP  for
further investigation.
Clinical  Evaluation:  Thorough  clinical  ophthalmic  and
electrophysiological examinations were performed in both
affected  patients,  which  included  a  comprehensive
ophthalmological  and  family  history,  funduscopic
examination  after  pupillary  dilation,  static  perimetry,  best
corrected visual acuity exam, and color vision testing. For the
STGD patient, fluorescein angiography was also performed.
Electrophysiological  assessment  included  full-field
electroretinogram  (ERG),  according  to  standards  of  the
International Society for Clinical Electrophysiology of Vision
[13,14].
DNA  extraction—Peripheral  blood  samples  with
ethylenediaminetetraacetic acid (EDTA) anticoagulant were
collected from each member of the family. Genomic DNA
was extracted using an automated DNA extractor (BioRobot
EZ1, QIAGEN, Hilden, Germany). Prior to use, DNA samples
were preserved frozen.
Genotyping microarray: STGD patients were analyzed for
variants on the ABCR400 microarray (www.asperbio.com),
as described elsewhere [7]. The 50 exons of the ABCA4 gene,
including the intron-exon junctions, were amplified by PCR
primers  previously  described  [15]  to  confirm  the  results
obtained from the microarray.
LCA and early-onset samples were screened on the LCA
genotyping microarray (www.asperbio.com), as previously
reported [16]. The 12 exons of the CRB1 gene, including the
intron-exon  boundaries,  were  amplified  by  PCR  and
sequenced with primers previously described [17] to test the
results.
Direct  sequencing:  Sequencing  reactions  were  performed
using the 4 dye terminator cycle sequencing ready reaction kit
(dRhodamine  DNA  Sequencing  Kit;  Applied  Biosystems,
Foster  City,  California).  Sequence  products  were  purified
through  fine  columns  (Sephadex  G-501;  Princetown
Separations, Adelphia, New Jersey) and resolved in an ABI
Prism 3100 (Applied Biosystems).
Denaturing  high-performance  liquid  chromatography:
Denaturing  high-performance  liquid  chromatography
(dHPLC)  sample  screening  was  performed  on  a  DNA
fragment analysis system (WAVE; Transgenomic, Omaha,
Nebraska). The PCR products (5 μl) were loaded on a C18
reversed-phase  column  (DnaSep  column;  Transgenomic).
Hetero-  and  homodimer  analysis  was  performed  with  an
acetonitrile  gradient  formed  by  mixing  buffers  A  and  B
(WAVE  Optimized,  Transgenomic).  The  flow  rate  was
0.9 mL/min, and DNA was detected at 260 nm. For each DNA
region,  dHPLC  conditions  were  established  by  a  triple
analysis 1 °C to 3 °C above and below the mean melting
temperature predicted by software simulation.
Because dHPLC usually does not differentiate between
the  wild-type  and  the  homozygous  mutant  sample,  all
unknown samples were mixed in a 3:1 proportion with a
control sample at the end of each PCR session. Before dHPLC
analysis, heteroduplexes were formed by denaturing the PCR
product at 95 °C for 5 min and cooling it to room temperature.
Haplotype analysis: Haplotypes were generated using three
microsatellite  markers  flanking  the  ABCA4  gene  (TEL-
D1S435-D1S2804-ABCA4-D1S236-CEN)  and  four
microsatellite  markers  flanking  the  CRB1  gene  (TEL-
D1S1660-CRB1-D1S2757-D1S2816-D1S408-CEN).  After
amplification  by  PCR,  fluorescent-labeled  products  were
mixed and electrophoresed on the ABI Prism 3100 (Applied
Biosystems).  For  haplotype  reconstruction,  we  used  an
informatic  program  (Cyrillic  version  2.1;
www.cyrillicsoftware.com).
RESULTS
Clinical findings: From our cohort of patients we selected one
family (Figures 1A and 1B) with two distinct phenotypes
(STGD  and  early-onset  RP  with  PPRPE)  for  further
investigation.  The  33-year-old  STGD  patient  initially
presented with visual acuity loss, photophobia, myopia, and
astigmatism  starting  at  the  age  of  14  years  (Figure  1A,
individual II:1). At that time, no restriction of visual fields or
night vision disturbances were noticed. At age 26, he had a
visual acuity of 10/100 in both eyes on clinical examination;
anterior  segments  were  normal.  Anterior  segments  were
normal, except for a slight subcapsular opacification of the
posterior pole of the lens. Funduscopy revealed a maculopathy
with RPE atrophy and hyperpigmentation and a few central
yellowish flecks; the peripheral retina showed no changes in
comparison to exam performed when he was 14 years. A slight
temporal  papillary  pallor  was  present,  and  retinal  vessels
showed no constriction (Figure 2). Static perimetry could not
reveal  central  scotomas,  but  shallow  relative  peripheral
scotomas in both eyes. The full-field ERG response showed
slightly  reduced—but  still  within  the  normal  range—
amplitudes for rod, mixed cone-rod, cone single flash, and
cone flicker, respectively. His 16-year-old sister presented a
different retinal phenotype, resembling early-onset RP. When
she was two years old, her parents noticed a deficit of the
peripheral visual field. At the age of 14, she developed night
vision  deficits  and  reduction  of  central  visual  acuity.
Ophthalmic evaluation of the patient at that time documented
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263reduced visual acuity (10/100 right eye, 20/100 left eye) and
diminished  visual  fields,  hyperopia,  astigmatism,  and
nystagmus.  Anterior  segments  were  normal.  Funduscopy
revealed roundish pigments distributed across the entire retina
including  peripheral  retina,  posterior  pole,  and  macular
region. The retinal vessels showed filliform constriction, and
the optic disc was normal. Visual fields were concentrically
constricted with small remaining central and nasal islands
(less than 10 degrees). ERG responses (photopic and scotopic)
were not discernible from noise anymore. The last fundus
examination was performed when she was 26 years old. It
showed pigment spots homogeneously scattered through the
retina with preservation of the PPRPE (Figure 3).
Molecular  analyses:  This  family  has  been  previously
analyzed [18,19]. In this molecular study, we described a 33-
year-old  man  diagnosed  with  STGD  (II:1),  who  was
Figure  1.  Pedigrees  from  a  Spanish
family cosegregating Stargardt disease
and early-onset retinitis pigmentosa. A:
Haplotype  analysis  showing
microsatellite  markers  flanking  the
ABCA4 gene (TEL-D1S435-D1S2804-
ABCA4-D1S236-CEN)  confirmed  the
Stargardt disease phenotype in II:1. His
affected sister (II:4) was found to be a
carrier of one disease-associated allele.
B:  Haplotype  analysis  with  markers
flanking  the  CRB1  gene  (TEL-
D1S1660-CRB1- D1S2757- D1S2816-
D1S408-CEN)  showed  cosegregation
of the disease. Three brothers (II:1, II:2,
II:3) were found to be carriers of the
p.Cys948Tyr allele.
Figure 2. Funduscopic photograph of a
patient  with  Stargardt  disease.
Funduscopy  revealed  a  maculopathy
with retinal pigment epithelium atrophy
and hyperpigmentation and few central
yellowish  flecks.  A  slight  temporal
papillary pallor was present and retinal
vessels showed no constriction.
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264homozygous  for  the  missense  ABCA4  p.Asn1805Asp  (c.
5413A>G)  mutation.  No  other  pathogenic  mutation  was
found  in  the  screening  of  the  gene  using  the  ABCR400
microarray. Four other members of the family, both parents
and two siblings of the proband, were heterozygous for the
ABCA4 c.5413A>G allele. While the parents and the brother
were unaffected, the sister presented with a severe early onset
arRP, which could not be explained by the ABCA4 genotype.
Although  she  was  tested  for  novel  ABCA4  mutations  by
dHPLC,  no  additional  variants  were  found.  Haplotype
analyses confirmed the segregation of the disease-associated
allele in this family (Figure 1A).
Following these molecular analyses, the affected sister
with the early-onset RP phenotype was tested for mutations
by screening on the LCA microarray. She was found to be
heterozygous  for  the  CRB1  p.Cys948Tyr  (c.2843G>A)
mutation.  Her  three  brothers  also  carried  this  change.
Haplotype analyses showed cosegregation within the family
(Figure 1B). Following, the 12 exons of the CRB1 gene were
screened  for  variants  by  dHPLC,  where  DNA  fragment
corresponding to exon 7 showed abnormal chromatographic
pattern.  Sequence  analysis  of  the  fragment  led  to  the
identification  of  the  novel  p.Trp822ter  (c.2465G>A)
mutation, which was also present in her healthy mother.
DISCUSSION
Retinal  dystrophies  are  genetically  and  clinically
heterogeneous.  Through  the  course  of  a  conventional
screening  performed  on  Spanish  families  with  retinal
dystrophies,  we  identified  one  family  with  two  siblings
affected  by  STGD  and  early-onset  RP,  respectively.
Molecular analyses revealed that mutations in two different
genes were implicated: ABCA4 and CRB1. The STGD patient
carried the homozygous p.Asn1805Asp allele in the ABCA4
gene, while the RP patient had the disease-associated alleles
p.Cys948Tyr  and  p.Trp822ter  cosegregating  in  the  CRB1
gene.
The p.Asn1805Asp allele may act as a modifying factor
for  the  RP  phenotype  in  the  female  patient.  Similarly,  a
possible modifier effect of the mutant CRB1 allele for the
STGD patient could be involved.
In  previous  analyses  performed  in  this  family,
homozygosity  was  tested  by  haplotype  construction  with
markers  close  to  several  RP  genes,  due  to  suspected
consanguinity. In no case was the affected sister found to be
homozygous  for  any  of  these  screened  regions  [19].  Our
haplotype analysis neither revealed homozygosity for markers
close to ABCA4 and CRB1 genes.
Several families with both STGD and arRP have been
reported  and  associated  to  different  ABCA4  mutations
[19-23]. To the best of our knowledge, this report is the first
description of two different genes implicated in two distinct
autosomal recessive retinal dystrophies in one family. To date,
there has been a description of one consanguineous family
segregating mutations in two different genes, both causing
Bardet Biedl Syndrome [24].
Thompson and colleagues suggested that the total number
of recessive mutations per chromosome in any one individual
may be low [25]. However, the family in the present study is
segregating  two  autosomal  recessive  ophthalmologic
diseases, with mutations in two different genes, both located
at chromosome 1.
The present study was part of an analysis performed on
129 Spanish families segregating different retinal dystrophies
due to mutations in ABCA4. In this work, a total of 18 patients
were diagnosed of arRP. Nevertheless, we did not identify any
patient harbouring both disease-associated alleles. Therefore,
we could not establish a RP phenotype caused by mutations
in this particular gene [26]. Similarly, Valverde et al. recently
observed  that  ABCA4  disease-associated  variants  are
implicated  in  STGD  and  CRD  phenotypes,  but  their
implication  in  RP  still  remains  unclear.  However,  a
modulating effect could be suspected [27].
The relative large sizes of these genes, containing 50 and
12  exons  respectively,  make  the  molecular  scanning  of
ABCA4  and  CRB1  particularly  labor-intensive.  The
ABCR400 and LCA chips have become reliable and rapid
mutation  detection  tools.  However,  because  of  the  high
frequency of rare mutations reported in these genes, additional
mutational scanning should be performed by dHPLC. This
technique is especially applicable for those ABCA4/CRB1
patients for whom chips have found one or no mutations.
Figure 3. Funduscopic photograph of a
patient  with  autosomal  recessive
retinitis  pigmentosa.  Funduscopy
showed pigment spots homogeneously
scattered  through  the  retina  with
preservation of the paraarteriolar retinal
pigmentary epithelium.
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265In  this  family,  two  distinct  retinal  dystrophies
cosegregated  with  mutations  in  two  different  genes.  An
accurate  clinical  diagnosis  obtained  from  comprehensive
ophthalmologic  examination  provides  the  basis  for
conducting the molecular analysis of one particular gene. The
identification  of  the  causative  mutation  was  helpful  for
confirming diagnosis and providing genetic counseling and
possibly  predicting  the  further  course  of  the  disease.  The
presence  of  two  different  phenotypes  associated  with
mutations in two distinct genes in one single family must be
considered especially when dealing with retinal dystrophies
that bear high carrier frequencies in general population.
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